Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 100 matching records.
100 results — page 1 of 5
- Level AMeta-analysisPubMed
Antifibrotic efficacy of adipose-derived mesenchymal stem cell-based therapeutic strategies in pre-clinical models of pulmonary fibrosis: A systematic review and meta-analysis.
Meta-analysis on Scar, published in Eur J Pharmacol (2026) — summary generated from the PubMed abstract.
- 2026
Eur J Pharmacol - Level DNarrative ReviewEurope PMC
Targeting ferroptosis to enhance the efficacy of mesenchymal stem cell-based treatments for intervertebral disc degeneration
Narrative Review on Disc Degeneration, published in Int J Biol Sci (2025) — summary generated from the PubMed abstract.
- 2025
Int J Biol Sci15 citations - Level DNarrative ReviewEurope PMC
Application of biomaterials in mesenchymal stem cell based endometrial reconstruction: current status and challenges
Narrative Review, published in Front Bioeng Biotechnol (2025) — summary generated from the PubMed abstract.
- 2025
Front Bioeng Biotechnol8 citations - Level AMeta-analysisPubMed
Efficacy of mesenchymal stem cell-based therapies in the treatment of perianal fistulizing Crohn's disease: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 596 on Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 596
Stem Cell Res Ther6 citations - Level DNarrative ReviewEurope PMC
Cellular mechanical memory: a potential tool for mesenchymal stem cell-based therapy
Narrative Review on Scar, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther10 citations - Level BClinical TrialPubMed
The promise of cell-based therapies in diabetes: A review of mesenchymal stem cell applications and trials.
Clinical Trial on Type 2 Diabetes, Immune Modulation, Autoimmune Research, published in Biochimie (2025) — summary generated from the PubMed abstract.
- 2025
Biochimie - Level AMeta-analysisEurope PMC
Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis
Meta-analysis on Type 2 Diabetes, Immune Modulation, published in World J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
World J Stem Cells1 citations - Level CProspective StudyPubMed
Interleukin-27-adipose-derived mesenchymal stromal cell-based gene therapy attenuates inflammation in lipopolysaccharide-induced acute respiratory distress syndrome.
Prospective Study on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther1 citations - Level CProspective StudyPubMed
Comparison of biological properties of human adipose tissue-derived mesenchymal stem/ stromal cells from healthy and diabetic donors: consequences for cell-based medicinal product development.
Prospective Study on Osteoarthritis, Type 2 Diabetes, Cardiovascular Disease, published in Cardiovasc Diabetol (2025) — summary generated from the PubMed abstract.
- 2025
Cardiovasc Diabetol - Level DNarrative ReviewPubMed
Mesenchymal and Pluripotent Stem Cell-Based Strategies for Cardiac Regeneration: Mechanisms, Challenges, and Future Directions.
Narrative Review on Cardiovascular Disease, Immune Modulation, published in Biotechnol J (2025) — summary generated from the PubMed abstract.
- 2025
Biotechnol J - Level DNarrative ReviewEurope PMC
Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-based strategies for treating neuroinflammation and promoting tissue repair
Narrative Review on Neuroinflammation, Immune Modulation, published in Front Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Front Immunol1 citations - Level DNarrative ReviewEurope PMC
How artificial intelligence can enable personalized mesenchymal stem cell-based therapeutic strategies in systemic lupus erythematosus
Narrative Review on Immune Modulation, Autoimmune Research, published in Front Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Front Immunol1 citations - Level AMeta-analysisEurope PMC
Mesenchymal stem cell-based therapy for osteoarthritis: a systematic review and meta-analysis of clinical outcomes and functional recovery
Meta-analysis with a reported sample of 811 on Osteoarthritis, Cartilage Damage, published in Front Cell Dev Biol (2025) — summary generated from the PubMed abstract.
- 2025
- n = 811
Front Cell Dev Biol1 citations - Level BClinical TrialPubMed
Interleukins and interferons in mesenchymal stromal stem cell-based gene therapy of cancer.
Clinical Trial on Systemic / IV, published in Cytokine Growth Factor Rev (2024) — summary generated from the PubMed abstract.
- 2024
Cytokine Growth Factor Rev - Level ASystematic ReviewEurope PMC
Mesenchymal stem cell based therapies for uveitis: a systematic review of preclinical studies
Systematic Review with a reported sample of 12, published in Eye (Lond) (2024) — summary generated from the PubMed abstract.
- 2024
- n = 12
Eye (Lond)2 citations - Level ASystematic ReviewEurope PMC
Mesenchymal stem cell-based therapies for treating well-studied neurological disorders: a systematic review
Systematic Review on Spinal Cord Injury, Neuroinflammation, published in Front Med (Lausanne) (2024) — summary generated from the PubMed abstract.
- 2024
Front Med (Lausanne)7 citations - Level ASystematic ReviewEurope PMC
Mesenchymal Stem Cell-Based Therapies for Temporomandibular Joint Repair: A Systematic Review of Preclinical Studies
Systematic Review on Osteoarthritis, Cartilage Damage, Immune Modulation, published in Cells (2024) — summary generated from the PubMed abstract.
- 2024
Cells8 citations - Level DNarrative ReviewEurope PMC
Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer-Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies
Narrative Review, published in Cells (2024) — summary generated from the PubMed abstract.
- 2024
Cells12 citations - Level DNarrative ReviewEurope PMC
Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction
Narrative Review on Cardiovascular Disease, Scar, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther8 citations - Level DNarrative ReviewEurope PMC
Multipotent mesenchymal stromal/stem cell-based therapies for acute respiratory distress syndrome: current progress, challenges, and future frontiers
Narrative Review on Chronic Inflammation, Immune Modulation, published in Braz J Med Biol Res (2024) — summary generated from the PubMed abstract.
- 2024
Braz J Med Biol Res3 citations - Level DLaboratory StudyPubMed
Adipose Tissue-Mesenchymal Stem Cells Caused to Change the Methylation Status of hTERT Gene Promoter CpG Islands of Molt-4 Leukemia Cells as Cell-based Therapy.
Laboratory Study, published in Curr Mol Med (2023) — summary generated from the PubMed abstract.
- 2023
Curr Mol Med - Level DNarrative ReviewEurope PMC
Autologous Human Mesenchymal Stem Cell-Based Therapy in Infertility: New Strategies and Future Perspectives
Narrative Review, published in Biology (Basel) (2023) — summary generated from the PubMed abstract.
- 2023
Biology (Basel)8 citations - Level BClinical TrialEurope PMC
Mesenchymal stem cell-based therapy for female stress urinary incontinence
Clinical Trial, published in Front Cell Dev Biol (2023) — summary generated from the PubMed abstract.
- 2023
Front Cell Dev Biol6 citations - Level CProspective StudyPubMed
Human Adipose-Derived Mesenchymal Stem Cell-Based Microspheres Ameliorate Atherosclerosis Progression In Vitro.
Prospective Study, published in Stem Cells Dev (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cells Dev6 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406